Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol.
暂无分享,去创建一个
E. Sausville | Y. Pommier | T. Shimizu | A. Senderowicz | B. Parker | G. Kaur | W. Nieves-Neira | M. Taimi | G. Kohlhagen | M. Losiewicz | E A Sausville | Y Pommier | B W Parker | G Kaur | W Nieves-Neira | M Taimi | G Kohlhagen | T Shimizu | M D Losiewicz | A M Senderowicz | Tsunehiro Shimizu | W. Nieves‐Neira | G. Kaur
[1] A. Eastman,et al. Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. , 1992, Biochemical and biophysical research communications.
[2] Z. Darżynkiewicz,et al. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. , 1994, Leukemia.
[3] L. Magnelli,et al. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis. , 1995, Biochemical and biophysical research communications.
[4] S. Steinberg,et al. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Bernhard O. Palsson,et al. Cancer cell lines , 1999 .
[6] H. Sedlacek,et al. Antitumoral activity of flavone L-86-8275. , 1995, International journal of oncology.
[7] M. Raff,et al. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death , 1996, The Journal of cell biology.
[8] Y. Hirano,et al. A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. , 1995, Oncogene.
[9] L. Meijer. Chemical inhibitors of cyclin-dependent kinases. , 1996, Trends in cell biology.
[10] E. Sausville,et al. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. , 1994, Biochemical and biophysical research communications.
[11] Y. Pommier,et al. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. , 1994, Leukemia & lymphoma.
[12] M. Grever,et al. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. , 1995, Journal of the National Cancer Institute.
[13] D. Housman,et al. p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.
[14] P. Petit,et al. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis , 1995, The Journal of cell biology.
[15] Z. Darżynkiewicz,et al. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. , 1992, Cancer research.
[16] E. Sausville,et al. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[17] R. Schlegel,et al. Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases (*) , 1996, The Journal of Biological Chemistry.
[18] A. Eastman,et al. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. , 1993, Archives of biochemistry and biophysics.
[19] Z. Darżynkiewicz,et al. Effect of protease inhibitors on early events of apoptosis. , 1996, Experimental cell research.
[20] Y. Pommier,et al. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. , 1993, Experimental cell research.
[21] S H Kim,et al. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Kaufmann,et al. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. , 1996, Cancer research.
[23] A. Levitzki,et al. Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives. , 1994, Biochemical pharmacology.
[24] H. Rus,et al. Sublytic complement attack induces cell cycle in oligodendrocytes. , 1996, Journal of immunology.
[25] John Calvin Reed,et al. BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy , 1996, Journal of cellular biochemistry.
[26] E. Sausville,et al. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. , 1992, Journal of the National Cancer Institute.
[27] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[28] J. Li,et al. BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. , 1996, Experimental cell research.
[29] E. Sausville,et al. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. , 1996, Cancer research.
[30] E. Sausville,et al. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity. , 1993, Biochemical pharmacology.
[31] P. Lin,et al. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. , 1992, Cancer research.
[32] E. Sausville,et al. Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. , 1996, International journal of oncology.
[33] E. Gelmann,et al. p53 oncogene mutations in three human prostate cancer cell lines , 1993, The Prostate.
[34] B. Barres,et al. Programmed cell death and the control of cell survival. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[35] David S. Park,et al. Inhibitors of Cyclin-dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons (*) , 1996, The Journal of Biological Chemistry.
[36] L. Boscá,et al. 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes. , 1997, Molecular pharmacology.
[37] W. Mercer,et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.
[38] K W Kohn,et al. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. , 1995, Cancer research.
[39] Q. Dou,et al. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] N. Davidson,et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.
[41] K. Kohn,et al. Effects of DNA methylation on topoisomerase I and II cleavage activities. , 1994, The Journal of biological chemistry.
[42] A. Eastman. Apoptosis: a product of programmed and unprogrammed cell death. , 1993, Toxicology and applied pharmacology.
[43] G. Gores,et al. The role of proteases during apoptosis , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.